These observations suggest that CD24 can have cell type-specific effects on tumor initiation and growth, a notion supported by our finding that CD24 deficiency slightly but statistically significantly reduced tumor burden in Apc1572T/+ but not MMTV-PyMT mammary carcinomas. This evidence concerns the gene CD24 and breast carcinoma.